Mr. Kozy graduated from Kenyon College in 1974.Hugh Morrison was appointed to LivaNova's Board in October 2015. From January 2010 to June 2015, Dr. Rosenthal also served as Professor of Practice in the Biomedical Engineering Department at Boston University and has been appointed Professor of Practice, Emeritus, January 2016. Dr. Rosenthal served as a non-executive director, from 2000 until 2010, and as Chairman of the Remuneration Committee, from 2006 through 2009, of Renovo, Ltd., a U.K.-based pharmaceutical company that became publicly traded in 2006. Our customer service team is available Monday through Friday 7:30 am - 5:30 pm CT.
Earlier in his tenure, he was Group President of Kerr where he and his team focused on building a strong research and development pipeline while improving operational performance utilizing the Danaher Business System. Mr. Novak currently serves on the board of directors of Restoring Heroes Foundation, an organization devoted to assisting veterans with obtaining access to new and progressive therapies. North Wharf Road The company operates in three business franchises: Cardiac Surgery, Cardiac Rhythm Management and Neuromodulation, with operating headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S… Keyna Skeffington joined LivaNova in 2017, having worked in the medical device industry since 2004. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.LivaNova PLC operates as a medical technology company.
Mr. Kozy served as Executive Vice President and Chief Operating Officer at global medical technology company Becton, Dickinson and Company (BD) from 2011 until his retirement in 2016. By putting patients first, we’re committed to developing breakthrough treatments and innovations that improve patients’ quality of life every day. Mr. Bianchi has acquired 30 years of M&A and strategic advisory experience working for prime international financial institutions such as JPMorgan Chase (Paris), Morgan Grenfell (Milan), Citi (London) and Bankers Trust (Milan), where he served as General Manager and Head of the M&A and Corporate Finance division. At LivaNova, we understand the importance of … Dr. O'Kane is an expert advisor to the Stevenage Bioscience Catalyst Facility at GSK. LivaNova offers a diverse product portfolio with a differentiated pipeline.
Ms. Enxing Seng’s qualifications for service on the LivaNova Board include her broad experience and insights across strategy, marketing, sales, innovation, M&A and a variety of other medical device related areas.William Kozy was appointed to LivaNova’s Board in June 2018. From 2014 to 2019, she served on the boards of Solace Therapeutics, Claret Inc., Spirox Inc., FIRE 1 INC. and American Heart Association’s Go Red for Women Campaign. LivaNova develops medical solutions for the treatment of cardiovascular diseases.5 Merchant Place In addition to our Board, Mr. Moore currently serves on the board of directors of GI Dynamics, Inc. (Chairman), BrainScope Company, Inc. (Chairman), a company focused on traumatic brain injury, the BioHouston Executive Committee, Weldon School of Biomedical Engineering Advisory Board and the Epilepsy Foundation of America. From September 2008 through June 2012, he was a Managing Director at Callahan Advisors, LLC, an investment management company. Contact us to place an order or inquire about an existing order. Updating settings. Plus, we offer the only truly sutureless aortic valve replacement, PercevalAs pioneers of the VNS (Vagus Nerve Stimulation) TherapySomething went wrong. Prior to becoming Chief Executive Officer, Damien McDonald served as Chief Operating Officer of LivaNova. The Company focuses on neuromodulation, as well as cardiac surgery and rhythm management. Something went wrong. She earned an MBA from Northwestern University’s Kellogg Graduate School of Management in Marketing and Finance and a Bachelor of Science Degree in Business Administration from Miami University. Focused on the Head and the Heart. As a worldwide leader in cardiovascular and neuromodulation solutions, we are dedicated to helping create meaningful Dr. O'Kane co founded, and from 1998-2010 was the Chief Scientific Officer and Executive Director of Renovo Group PLC (“Renovo''), a publicly listed U.K. biotech company.
Earlier in his tenure, he was Group President of Kerr where he and his team focused on building a strong research and development pipeline while improving operational performance utilizing the Danaher Business System. Mr. Novak currently serves on the board of directors of Restoring Heroes Foundation, an organization devoted to assisting veterans with obtaining access to new and progressive therapies. North Wharf Road The company operates in three business franchises: Cardiac Surgery, Cardiac Rhythm Management and Neuromodulation, with operating headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S… Keyna Skeffington joined LivaNova in 2017, having worked in the medical device industry since 2004. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.LivaNova PLC operates as a medical technology company.
Mr. Kozy served as Executive Vice President and Chief Operating Officer at global medical technology company Becton, Dickinson and Company (BD) from 2011 until his retirement in 2016. By putting patients first, we’re committed to developing breakthrough treatments and innovations that improve patients’ quality of life every day. Mr. Bianchi has acquired 30 years of M&A and strategic advisory experience working for prime international financial institutions such as JPMorgan Chase (Paris), Morgan Grenfell (Milan), Citi (London) and Bankers Trust (Milan), where he served as General Manager and Head of the M&A and Corporate Finance division. At LivaNova, we understand the importance of … Dr. O'Kane is an expert advisor to the Stevenage Bioscience Catalyst Facility at GSK. LivaNova offers a diverse product portfolio with a differentiated pipeline.
Ms. Enxing Seng’s qualifications for service on the LivaNova Board include her broad experience and insights across strategy, marketing, sales, innovation, M&A and a variety of other medical device related areas.William Kozy was appointed to LivaNova’s Board in June 2018. From 2014 to 2019, she served on the boards of Solace Therapeutics, Claret Inc., Spirox Inc., FIRE 1 INC. and American Heart Association’s Go Red for Women Campaign. LivaNova develops medical solutions for the treatment of cardiovascular diseases.5 Merchant Place In addition to our Board, Mr. Moore currently serves on the board of directors of GI Dynamics, Inc. (Chairman), BrainScope Company, Inc. (Chairman), a company focused on traumatic brain injury, the BioHouston Executive Committee, Weldon School of Biomedical Engineering Advisory Board and the Epilepsy Foundation of America. From September 2008 through June 2012, he was a Managing Director at Callahan Advisors, LLC, an investment management company. Contact us to place an order or inquire about an existing order. Updating settings. Plus, we offer the only truly sutureless aortic valve replacement, PercevalAs pioneers of the VNS (Vagus Nerve Stimulation) TherapySomething went wrong. Prior to becoming Chief Executive Officer, Damien McDonald served as Chief Operating Officer of LivaNova. The Company focuses on neuromodulation, as well as cardiac surgery and rhythm management. Something went wrong. She earned an MBA from Northwestern University’s Kellogg Graduate School of Management in Marketing and Finance and a Bachelor of Science Degree in Business Administration from Miami University. Focused on the Head and the Heart. As a worldwide leader in cardiovascular and neuromodulation solutions, we are dedicated to helping create meaningful Dr. O'Kane co founded, and from 1998-2010 was the Chief Scientific Officer and Executive Director of Renovo Group PLC (“Renovo''), a publicly listed U.K. biotech company.